Vtama in Psoriasis Patients Being Treated With Biologics.

Part of paid clinical trials in East Windsor, New Jersey.

Sponsor
Psoriasis Treatment Center of Central New Jersey
Study ID
NCT06103695
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Tapinarof — DRUG
    Add on Vtama (tapinarof) to biololgic therapy

Study Details

Open label study to assess 12 weeks of add-on VTAMA® (tapinarof) Cream, 1% QD in patients with ≥3% BSA who have received biologic therapy for at least 24 weeks.

Key Dates

Start date
Feb 27, 2023
Status verified
Oct 2023
Primary completion
Oct 18, 2023
Completion
Oct 18, 2023

Study Design

Enrollment
30 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Other: Vtama
    open label Vtama

Primary Outcome Measure

Body surface area ≤1% [ Time Frame: 12 weeks ]

Locations (1)

FacilityCityStateZIPSite coordinators
Schweiger Derm GroupEast WindsorNew Jersey08520-

Find similar trials in East Windsor, NJ

By condition
Psoriasis
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Schweiger Derm Group· East Windsor, NJ

Related Studies